Target intelligence / Profile preview

Idiotype determinant (Id)

Target
Id
Molecular classification
Immunoglobulin, T-cell receptor, Surface antigen
01

Overview

An idiotype determinant is the unique collection of antigenic features, known as idiotopes, located within the variable regions of an immunoglobulin or T-cell receptor (TCR) molecule. These determinants are formed by the specific amino acid sequences of the complementarity-determining regions (CDRs) that define the molecule's antigen-binding specificity (Janeway et al., 2001). In clinical oncology, particularly for B-cell malignancies like follicular lymphoma and multiple myeloma, the idiotype expressed by the malignant clone serves as a strictly tumor-specific antigen, as it is unique to the progeny of the original transformed cell and absent from healthy tissues (Levy, 1999). This extreme specificity has made idiotype determinants a primary target for personalized immunotherapy, most notably in the form of idiotype vaccines where a patient's own tumor-derived protein is used to stimulate an anti-tumor immune response (Schuster et al., 2011). Despite their potential, therapeutic challenges include the requirement for highly individualized and costly manufacturing processes, as well as the risk of tumor escape through the selection of clones that no longer express the targeted idiotype (Bendig et al., 2010).

Other names
IdiotopeImmunoglobulin variable region determinantB-cell receptor idiotypeT-cell receptor idiotypeClonal antigen
02

Mechanism of action

Active immunization inducing a host immune response against patient-specific clonal antigens; Passive immunization using anti-idiotype antibodies to mimic antigens or block receptors.

03

Biological functions

Antigen recognitionImmune cell signalingClonal selectionImmune regulation
04

Disease associations

B-cell lymphomaMultiple myelomaAutoimmune diseaseChronic lymphocytic leukemia
05

Safety considerations

Patient-specific manufacturing requirementsLow immunogenicity requiring adjuvantsTumor antigen escape/downregulationInjection site reactions
06

Interacting drugs

Dasiprotimut-T

3 more in the full profile.

07

Biomarkers

Clonal immunoglobulin sequencePatient-specific idiotype protein levelV-D-J gene rearrangement

Beyond the preview

Go deeper on Idiotype determinant (Id).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idiotype determinant (Id).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call